scholarly journals Impact of thoracic radiation therapy after chemotherapy on survival in extensive‐stage small cell lung cancer: A propensity score‐matched analysis

2019 ◽  
Vol 10 (4) ◽  
pp. 799-806
Author(s):  
Lei Deng ◽  
ZongMei Zhou ◽  
ZeFen Xiao ◽  
DongFu Chen ◽  
QinFu Feng ◽  
...  
2011 ◽  
Vol 2011 ◽  
pp. 1-4
Author(s):  
Edward F. Miles ◽  
Laura L. Jacimore ◽  
John W. Nelson

Small cell lung cancer (SCLC) constitutes approximately 16% of all primary lung cancers, with more than 35,000 new cases per year. Two-thirds of patients present with extensive stage disease (ES-SCLC) due to a tendency to metastasize early. Outcomes remain poor, with a median survival of approximately 10 months and a two-year overall survival of <10%. Current recommendations call for combination chemotherapy alone in patients without localized symptoms. Thoracic radiation therapy following a good clinical response is controversial. We report on a patient with ES-SCLC that had an excellent response to chemotherapy and underwent whole brain radiotherapy for a known brain metastasis and consolidative radiotherapy to the thorax. His latest follow-up demonstrates only a stable residual pulmonary nodule and no evidence of active metastatic disease. ES-SCLC is a relatively common presentation with a variable burden of metastatic disease. In the absence of randomized trials demonstrating the efficacy of thoracic radiation therapy, the community radiation oncologist is placed in a difficult position when addressing these patients, particularly those with otherwise good performance status and a good response to initial systemic chemotherapy. More research in this area is sorely needed to help guide treatment recommendations.


2017 ◽  
Vol 13 (13) ◽  
pp. 1149-1158 ◽  
Author(s):  
Changchun An ◽  
Wang Jing ◽  
Yan Zhang ◽  
Sujing Liu ◽  
Haiyong Wang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document